Tuberculosis and COVID-19 co-infection: description of the global cohort
Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the TB/COVID-19 co-infected individuals from a prospective, anonymised, multicountry register-based cohort with special focus on the determinants of mortal...
Gespeichert in:
| Veröffentlicht in: | The European respiratory journal Jg. 59; H. 3 |
|---|---|
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
01.03.2022
|
| Schlagworte: | |
| ISSN: | 1399-3003, 1399-3003 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the TB/COVID-19 co-infected individuals from a prospective, anonymised, multicountry register-based cohort with special focus on the determinants of mortality and other outcomes.
We enrolled all patients of any age with either active TB or previous TB and COVID-19. 172 centres from 34 countries provided individual data on 767 TB-COVID-19 co-infected patients, (>50% population-based).
Of 767 patients, 553 (74.0%) out of 747 had TB before COVID-19 (including 234 out of 747 with previous TB), 71 (9.5%) out of 747 had COVID-19 first and 123 (16.5%) out of 747 had both diseases diagnosed within the same week (n=35 (4.6%) on the same day). 85 (11.08%) out of 767 patients died (41 (14.2%) out of 289 in Europe and 44 (9.2%) out of 478 outside Europe; p=0.03): 42 (49.4%) from COVID-19, 31 (36.5%) from COVID-19 and TB, one (1.2%) from TB and 11 from other causes. In the univariate analysis on mortality the following variables reached statistical significance: age, male gender, having more than one comorbidity, diabetes mellitus, cardiovascular disease, chronic respiratory disease, chronic renal disease, presence of key symptoms, invasive ventilation and hospitalisation due to COVID-19. The final multivariable logistic regression model included age, male gender and invasive ventilation as independent contributors to mortality.
The data suggest that TB and COVID-19 are a "cursed duet" and need immediate attention. TB should be considered a risk factor for severe COVID disease and patients with TB should be prioritised for COVID-19 preventative efforts, including vaccination. |
|---|---|
| AbstractList | Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the TB/COVID-19 co-infected individuals from a prospective, anonymised, multicountry register-based cohort with special focus on the determinants of mortality and other outcomes.
We enrolled all patients of any age with either active TB or previous TB and COVID-19. 172 centres from 34 countries provided individual data on 767 TB-COVID-19 co-infected patients, (>50% population-based).
Of 767 patients, 553 (74.0%) out of 747 had TB before COVID-19 (including 234 out of 747 with previous TB), 71 (9.5%) out of 747 had COVID-19 first and 123 (16.5%) out of 747 had both diseases diagnosed within the same week (n=35 (4.6%) on the same day). 85 (11.08%) out of 767 patients died (41 (14.2%) out of 289 in Europe and 44 (9.2%) out of 478 outside Europe; p=0.03): 42 (49.4%) from COVID-19, 31 (36.5%) from COVID-19 and TB, one (1.2%) from TB and 11 from other causes. In the univariate analysis on mortality the following variables reached statistical significance: age, male gender, having more than one comorbidity, diabetes mellitus, cardiovascular disease, chronic respiratory disease, chronic renal disease, presence of key symptoms, invasive ventilation and hospitalisation due to COVID-19. The final multivariable logistic regression model included age, male gender and invasive ventilation as independent contributors to mortality.
The data suggest that TB and COVID-19 are a "cursed duet" and need immediate attention. TB should be considered a risk factor for severe COVID disease and patients with TB should be prioritised for COVID-19 preventative efforts, including vaccination. Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the TB/COVID-19 co-infected individuals from a prospective, anonymised, multicountry register-based cohort with special focus on the determinants of mortality and other outcomes.BACKGROUNDInformation on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the TB/COVID-19 co-infected individuals from a prospective, anonymised, multicountry register-based cohort with special focus on the determinants of mortality and other outcomes.We enrolled all patients of any age with either active TB or previous TB and COVID-19. 172 centres from 34 countries provided individual data on 767 TB-COVID-19 co-infected patients, (>50% population-based).METHODSWe enrolled all patients of any age with either active TB or previous TB and COVID-19. 172 centres from 34 countries provided individual data on 767 TB-COVID-19 co-infected patients, (>50% population-based).Of 767 patients, 553 (74.0%) out of 747 had TB before COVID-19 (including 234 out of 747 with previous TB), 71 (9.5%) out of 747 had COVID-19 first and 123 (16.5%) out of 747 had both diseases diagnosed within the same week (n=35 (4.6%) on the same day). 85 (11.08%) out of 767 patients died (41 (14.2%) out of 289 in Europe and 44 (9.2%) out of 478 outside Europe; p=0.03): 42 (49.4%) from COVID-19, 31 (36.5%) from COVID-19 and TB, one (1.2%) from TB and 11 from other causes. In the univariate analysis on mortality the following variables reached statistical significance: age, male gender, having more than one comorbidity, diabetes mellitus, cardiovascular disease, chronic respiratory disease, chronic renal disease, presence of key symptoms, invasive ventilation and hospitalisation due to COVID-19. The final multivariable logistic regression model included age, male gender and invasive ventilation as independent contributors to mortality.RESULTSOf 767 patients, 553 (74.0%) out of 747 had TB before COVID-19 (including 234 out of 747 with previous TB), 71 (9.5%) out of 747 had COVID-19 first and 123 (16.5%) out of 747 had both diseases diagnosed within the same week (n=35 (4.6%) on the same day). 85 (11.08%) out of 767 patients died (41 (14.2%) out of 289 in Europe and 44 (9.2%) out of 478 outside Europe; p=0.03): 42 (49.4%) from COVID-19, 31 (36.5%) from COVID-19 and TB, one (1.2%) from TB and 11 from other causes. In the univariate analysis on mortality the following variables reached statistical significance: age, male gender, having more than one comorbidity, diabetes mellitus, cardiovascular disease, chronic respiratory disease, chronic renal disease, presence of key symptoms, invasive ventilation and hospitalisation due to COVID-19. The final multivariable logistic regression model included age, male gender and invasive ventilation as independent contributors to mortality.The data suggest that TB and COVID-19 are a "cursed duet" and need immediate attention. TB should be considered a risk factor for severe COVID disease and patients with TB should be prioritised for COVID-19 preventative efforts, including vaccination.CONCLUSIONThe data suggest that TB and COVID-19 are a "cursed duet" and need immediate attention. TB should be considered a risk factor for severe COVID disease and patients with TB should be prioritised for COVID-19 preventative efforts, including vaccination. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34764184$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj8tOwzAQRS0Eog_4AiSUJRsXjx-xzQ6VRytV6qawjWJ7QoPSuMTJgr-nFUViNXeOjkZzJ-S8jS0ScgNsBmDEPQhrBWNixrgShnLG4YyMj5Qe8fm_PCKTlD4Zg1wKuCQjIXUuwcgxWWwGh50fmpjqlJVtyObr9-UTBZv5SOu2Qt_XsX3IAibf1fvjksUq67eYfTTRlc3B28auvyIXVdkkvD7NKXl7ed7MF3S1fl3OH1fUS616qvDwtDdGQbDglQ4B0GGwpRPMSpYLib4yObAQtHKW5U4x4NpWxgWpreBTcvd7d9_FrwFTX-zq5LFpyhbjkAqurJZGaMYP6u1JHdwOQ7Hv6l3ZfRd_7fkPV7Zcig |
| CitedBy_id | crossref_primary_10_2147_IDR_S346375 crossref_primary_10_1183_13993003_00925_2023 crossref_primary_10_1192_bji_2023_3 crossref_primary_10_1186_s12879_024_09395_w crossref_primary_10_1080_14760584_2024_2425283 crossref_primary_10_3389_fcimb_2022_888582 crossref_primary_10_3389_fmed_2025_1582726 crossref_primary_10_4236_aid_2025_153032 crossref_primary_10_4103_ijmy_ijmy_189_23 crossref_primary_10_15446_revfacmed_v72n1_109537 crossref_primary_10_1002_iid3_1275 crossref_primary_10_1016_j_pulmoe_2023_05_008 crossref_primary_10_1007_s12038_025_00496_5 crossref_primary_10_3390_tropicalmed7110367 crossref_primary_10_52692_1857_0011_2023_3_77_08 crossref_primary_10_1016_j_pulmoe_2022_01_018 crossref_primary_10_3389_fphar_2022_1065124 crossref_primary_10_1183_13993003_02396_2022 crossref_primary_10_5588_ijtldopen_24_0035 crossref_primary_10_2147_IDR_S524300 crossref_primary_10_3390_jcm14082782 crossref_primary_10_1016_j_arbres_2022_07_013 crossref_primary_10_1093_ije_dyad012 crossref_primary_10_1186_s12879_024_09947_0 crossref_primary_10_1136_bmjopen_2023_080623 crossref_primary_10_5588_ijtldopen_25_0016 crossref_primary_10_1016_j_pulmoe_2022_01_015 crossref_primary_10_1016_j_pulmoe_2023_07_002 crossref_primary_10_3389_fmed_2024_1416197 crossref_primary_10_1183_20734735_0176_2021 crossref_primary_10_3389_fimmu_2023_1223260 crossref_primary_10_3389_fmed_2022_971008 crossref_primary_10_1016_j_jiph_2024_102511 crossref_primary_10_3389_fpubh_2025_1543647 crossref_primary_10_3390_v15010175 crossref_primary_10_7717_peerj_18041 crossref_primary_10_1371_journal_pgph_0004471 crossref_primary_10_7759_cureus_46353 crossref_primary_10_1016_j_sciaf_2025_e02680 crossref_primary_10_1002_ppul_27232 crossref_primary_10_3389_fimmu_2023_1244556 crossref_primary_10_3390_app15105423 crossref_primary_10_1590_s1678_9946202466065 crossref_primary_10_3390_idr17010011 crossref_primary_10_12688_wellcomeopenres_19275_2 crossref_primary_10_3346_jkms_2025_40_e38 crossref_primary_10_12688_wellcomeopenres_19275_1 crossref_primary_10_2147_JMDH_S463859 crossref_primary_10_3390_v16020260 crossref_primary_10_3389_fcimb_2023_1273019 crossref_primary_10_4103_ijmy_ijmy_19_24 crossref_primary_10_7759_cureus_44857 crossref_primary_10_3389_fimmu_2023_1250198 crossref_primary_10_3390_microorganisms11092277 crossref_primary_10_1007_s40808_022_01430_6 crossref_primary_10_1183_13993003_00493_2022 crossref_primary_10_1142_S0218348X25400997 crossref_primary_10_3390_microorganisms11092191 crossref_primary_10_3390_ijms24119670 crossref_primary_10_1186_s12879_023_08412_8 crossref_primary_10_1016_j_arbres_2023_09_002 crossref_primary_10_3389_fpubh_2024_1413604 crossref_primary_10_3389_fimmu_2023_1292486 crossref_primary_10_3389_fmed_2025_1554723 crossref_primary_10_3389_fpubh_2023_1247661 crossref_primary_10_3389_fpubh_2023_1117101 crossref_primary_10_2147_IDR_S370837 crossref_primary_10_1183_13993003_00149_2022 crossref_primary_10_3389_fmicb_2022_1061879 crossref_primary_10_3389_fpubh_2023_1226980 |
| ContentType | Journal Article |
| Copyright | Copyright ©The authors 2022. |
| Copyright_xml | – notice: Copyright ©The authors 2022. |
| CorporateAuthor | TB/COVID-19 Global Study Group |
| CorporateAuthor_xml | – name: TB/COVID-19 Global Study Group |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1183/13993003.02538-2021 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1399-3003 |
| ExternalDocumentID | 34764184 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- .55 .GJ 18M 1OC 2WC 31~ 3O- 53G 5GY 5RE 5VS 8-1 AAFWJ AAZMJ ABCQX ABJNI ABOCM ABSQV ACEMG ACGFO ACPRK ACXQS ADBBV ADDZX ADMOG ADYFA AENEX AFFNX AFHIN AFZJQ AIZTS AJAOE ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CAG CGR COF CS3 CUY CVF DIK E3Z EBS ECM EIF EJD F5P F9R GX1 H13 INIJC J5H KQ8 L7B LH4 LW6 NPM OK1 P2P PQQKQ R0Z RHI TER TR2 W8F WOQ X7M ZE2 ZGI ZXP ~02 7X8 |
| ID | FETCH-LOGICAL-c475t-5e993c8851d91c57dd1ebed9ab30940634ecf8610dd75b906b501279f8bd47932 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 113 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000792497500022&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1399-3003 |
| IngestDate | Sat Nov 01 14:33:32 EDT 2025 Thu Aug 28 04:23:13 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | Copyright ©The authors 2022. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c475t-5e993c8851d91c57dd1ebed9ab30940634ecf8610dd75b906b501279f8bd47932 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://erj.ersjournals.com/content/erj/59/3/2102538.full.pdf |
| PMID | 34764184 |
| PQID | 2597483702 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2597483702 pubmed_primary_34764184 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-03-01 |
| PublicationDateYYYYMMDD | 2022-03-01 |
| PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | The European respiratory journal |
| PublicationTitleAlternate | Eur Respir J |
| PublicationYear | 2022 |
| References | 35450921 - Eur Respir J. 2022 Apr 21;59(4):2200493. doi: 10.1183/13993003.00493-2022. |
| References_xml | – reference: 35450921 - Eur Respir J. 2022 Apr 21;59(4):2200493. doi: 10.1183/13993003.00493-2022. |
| SSID | ssj0016431 |
| Score | 2.6451628 |
| Snippet | Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| SubjectTerms | Cohort Studies Coinfection - epidemiology COVID-19 Humans Male Prospective Studies Tuberculosis - complications Tuberculosis - epidemiology |
| Title | Tuberculosis and COVID-19 co-infection: description of the global cohort |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34764184 https://www.proquest.com/docview/2597483702 |
| Volume | 59 |
| WOSCitedRecordID | wos000792497500022&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvC6ttlNurteRKqlgq09VOmtJDu7UJCkNq2_350ktSdB8JLDQiCZTGa-mW8ehNzESjmpbMAAO2RCISMWc-dYEnInmnGkedko_CL7fTUa6UGVcMurssqlTSwMNWQGc-QNjsgXJ7Xw--knw61RyK5WKzTWSU14KINaLUcrFsF72zLg0sjvN0U1dchrcQPP8OjW-3yBusKD3zFm4Ws6u_99yj2yU6FM-lCqxT5Zs-kB2epVPPoh6Q4XiZ2ZxUeWT3Iap0Dbr-_PjyzQ1GRsWaCV3lGwP2aFZo56tEjLESIUN-vO5kfkrfM0bHdZtVOBmVBGcxZZ_95GeZwFOjCRBAj8ZwQdJwIn6bVEaI1THlMByCjRzVYSITmtnUoAk3D8mGykWWpPCW3pODYq8TFuxEMBoQIDTjotgQOopqqT66WMxl5nkYiIU5st8vFKSnVyUgp6PC2Ha4xFKFuhDzvP_nD3Odnm2I1QlIRdkJrzf6y9JJvmaz7JZ1eFMvhrf9D7BjsIu8s |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tuberculosis+and+COVID-19+co-infection%3A+description+of+the+global+cohort&rft.jtitle=The+European+respiratory+journal&rft.date=2022-03-01&rft.issn=1399-3003&rft.eissn=1399-3003&rft.volume=59&rft.issue=3&rft_id=info:doi/10.1183%2F13993003.02538-2021&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1399-3003&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1399-3003&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1399-3003&client=summon |